$GMRS

GMR Solutions plans to release Q3 results Nov. 9; its call follows the next morning.

GMR Solutions Inc. (GMRS) will release Q3 2026 results on Nov 9, 2026, followed by an earnings call on Nov 10. The company is the largest U.S. provider of emergency medical services, operating in 1,400 counties and serving 5.5 million patient encounters annually.

Original reporting
Published Oct 13, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$GMRS
Neutral
high confidence
Mentioned
$GMRS
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$GMRSNeutralMed
01

Why it matters

The announcement sets the timeline for investors to position ahead of the Q3 results, but without guidance the impact remains uncertain.

02

Market read

The upcoming earnings release is the primary catalyst; traders may adjust exposure based on expectations.

03

What to watch

Potential regulatory changes or contract wins/losses not disclosed could materially affect the stock post‑release.

Relevance 5/10Novelty 5/10Timing: ahead of earnings release on Nov 9

Background

GMR Solutions is the largest U.S. emergency medical services provider, operating both air and ground EMS across 1,400 counties.

Company-level read

Ticker impact

$GMRSNeutralHigh confidence
Context

GMR Solutions announced its Q3 2026 earnings will be released after market close on Nov 9, 2026.

Expected impact

possible swing either direction as market prices in the earnings surprise

Evidence & confidence

No guidance or numbers are provided; the only new fact is the release date, which typically leads to modest pre‑earnings positioning.

Market effects

The EMS sector may see heightened attention as analysts prepare for GMR's earnings, but no direct sector impact is indicated.

U.S. healthcare services market may experience modest trading activity around the release date.

Limited to investors tracking U.S. emergency medical services providers.

Counterpoint

If the market overestimates the earnings impact, a contrarian could stay flat or short ahead of the release.

Key entities

  • GMR Solutions Inc.

    Provider of emergency medical services, ticker GMRS.

Related articles

$GMRSMed

GMR Solutions Inc. Reports Financial Results

GMR Solutions Inc. (GMRS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ ​ GMR Solutions Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Reaffirms Full Year 2026 Guidance LEWISVILLE, Texas (August 12, 2026) — GMR Solutions Inc. (“GMR” or the “Company”) (NYSE: GMRS), the nation’s largest provider of em

$PBLSMed

Top Biotech Gainers: PBLS Soars Over 50%, CLOV Rallies On Legal Win, RNAZ, TMCI On Watch

Biotech stocks rose on varied catalysts. Parabilis (PBLS) debuted on Nasdaq, up 58% to $31.60 after pricing a $20.00 IPO of 33.5M shares for ~$670M gross proceeds. Clover Health (CLOV) gained 14% to $4.89 after a court ruling upgraded its 2026 PPO Star Rating to 4.5 from 3.5. Myomo (MYO) rose 17% to $1.54; Shoulder Innovations (SI) up 17% to $17.89; GMRS up 13% to $13.18.

$GMRSMedAI 9/10

Full Transcript: GMR Solutions Q1 2026 Earnings Call - GMR Solutions (NYSE:GMRS)

GMR Solutions (NYSE:GMRS) reported Q1 2026 revenue of $1.46 billion (+6.6% YoY) and adjusted EBITDA of $305 million (+9.7%). The company said its recent IPO leaves net leverage around 3.5x. It cited a 47% rise in 911 nurse navigation calls and nearly $47 million in incremental annualized revenue from new agreements. 2026 guidance targets $5.89–$6.18 billion revenue and high single-digit adjusted EBITDA growth.

$WTFCHighAI 8/10

Wintrust Financial Corporation Reports Record Net Income

WINTRUST FINANCIAL CORP (WTFC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Wintrust Financial Corporation 9700 W. Higgins Road, Suite 800, Rosemont, Illinois 60018 News Release FOR IMMEDIATE RELEASE October 19, 2026 FOR MORE INFORMATION CONTACT: David A. Dykstra, Vice Chairman & Chief Operating Officer (847) 939-9000 Amy Yuhn, Executive Vic

$SUPNLow

Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026

SUPERNUS PHARMACEUTICALS, INC. (SUPN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026 ROCKVILLE, Md., October 19, 2026 – Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializ